Research Report
Hinge Health, Inc. · Digital Health · United States · NYSE:HNGE
Overview
Hinge Health delivers a digital musculoskeletal care platform combining exercise therapy, wearable sensors and clinicians, sold to employers and health plans.
Hinge Health operates in Digital Health, headquartered in United States, and is currently classified as ipo. It is a maturing business founded in 2014 and today runs a large-scale operation of roughly 1.60K people. Private market participants most recently referenced the business at approximately $3.90B. Its product surface spans MSK Program, Enso Device, TrueMotion. The company monetizes primarily through per-member contracts with employers and health plans.
Company facts
- Founded
- 2014
- Headquarters
- San Francisco, USA
- Employees
- 1,600
- CEO
- Daniel Perez
- Sector
- Healthcare
- Model
- per-member contracts with employers and health plans
Investor network
The institutions backing the company, by conviction.
Lead investors
All investors
Path to public markets
IPO readiness is assessed at roughly 99% on our internal scale, reflecting scale, financial maturity and observed pre-listing signals. If current momentum holds, a listing could plausibly land around 2025 on the NYSE. Stronger, audited financial disclosure would be the clearest step toward genuine IPO readiness.
- s1 filingApr 21, 2025
- pricedMay 21, 2025Priced at $32 · raised $437M · Morgan Stanley, BofA Securities, Goldman Sachs
- listedMay 22, 2025
IPO parameters
- Readiness
- public
- Filing status
- effective
- Exchange
- NYSE
- Proposed ticker
- HNGE
- Expected
- Q2 2025
- Lock-up
- 180 days
The investment case
The core thesis on Hinge Health rests on its position within Digital Health, validated by backing from Tiger Global, Coatue, Insight Partners, having raised on the order of $1B to date. Reported revenue near $390M suggests the model has moved beyond early product-market fit into durable commercial traction.
Bull case
Bull case: Hinge Health compounds its lead in Digital Health, converts strong product engagement into expanding, high-margin revenue, and uses brand and balance-sheet strength to enter adjacent markets. A well-received public listing would provide currency for acquisitions and a re-rating toward best-in-class multiples.
Bear case
Bear case: growth normalizes faster than expected, competition compresses margins, and a tighter funding environment forces dilutive raises or down-rounds. In that scenario, secondary prices drift below prior marks and any IPO is delayed until conditions improve.
Growth drivers
Growth is driven by demand within Digital Health, particularly across MSK Program, Enso Device, TrueMotion. Expansion levers include new product lines, geographic reach, and deeper monetization of the existing customer base. Recurring revenue characteristics, where present, improve predictability and support a premium valuation multiple.
Key risks
Key risks include competitive pressure from peers such as Sword Health, Omada Health, Teladoc. A reliance on external financing exposes the company to shifts in private-market sentiment and the cost of capital. Private valuations can also lag public re-ratings, so a future listing or secondary transaction could reprice the business in either direction. As with any private company, disclosure is limited and figures shown here should be treated as estimates pending primary filings.
Competitive landscape
Hinge Health competes against Sword Health, Omada Health, Teladoc. Differentiation typically comes from product depth, distribution, switching costs, and the strength of its investor and talent base. The category is dynamic, and relative positioning can shift quickly as capital and attention rotate.
Filings & sources
| Form | Title | Filed |
|---|---|---|
| S-1 | Hinge Health S-1 | Apr 21, 2025 |
Data quality
Compiled from 3 sourced data points with an aggregate confidence of 75%. Public-company financials are pulled from SEC EDGAR; private valuations are the most recent publicly reported figures.
Last reviewed Jul 26, 2026. Verify against primary filings before relying on these figures.